Is PROCRIT Immunotherapy? Understanding the Mechanism and Role
•
4 min read
Despite being used to support patients undergoing cancer treatment, PROCRIT (epoetin alfa) is not a form of immunotherapy. Instead, it is an erythropoiesis-stimulating agent (ESA) that functions by stimulating the bone marrow to produce more red blood cells. This distinction is crucial for understanding its role in supportive care for anemia, a common side effect of chemotherapy and other medical conditions.